Fast Five Quiz: Precision Medicine and Genetic Testing for Colorectal Cancer

Ali Alqahtani, MD


June 17, 2022

Globally, colorectal cancer (CRC) ranks as the third leading cancer and the second leading cause of cancer-related death. Estimates suggest that > 1.9 million cases of CRC were diagnosed in 2020; in that same year, 0.9 million deaths were attributed to CRC. The global incidence of CRC is projected to reach 3.2 million in 2040, largely as a result of aging, population growth, and environmental risk factors related to westernization of lifestyle and diet. While traditional chemotherapy typically only extends survival for a few months in metastatic CRC, advances in surgical approaches and therapeutics are improving outcomes for many patients. Precision medicine, which seeks to identify the ideal treatment for individual patients by considering the molecular characteristics and specific vulnerabilities of their disease, is emerging as a promising and potentially practice-changing approach to the management of metastatic CRC. Recently, the use of next-generation sequencing has led to the development of a widening array of therapeutic options that aim to precisely match drugs with molecular alterations.

How familiar are you with genetic testing and precision medicine for CRC? Check your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.